Blue Bell Consulting:Home > Introduction

Blue Bell Scientific Technology Consulting (Shanghai) Co. Ltd., Blue Bell Consulting (BBC), is a premier consulting firm in China which bridges a commercial and science-based regulatory pathway between Chinese pharmaceutical products and global mainstream markets by engaging in international regulatory compliance, and registrations and applications of drug products. BBC’s unique advantages lie in its familiarity with international regulatory compliance policies, registration rules and application regulations, as well as current status of the Chinese pharmaceutical industry. BBC has associations not only with leading Chinese biomedical companies, but also with multinational companies and overseas clients. Finally, the company has ability in formulating global market strategy for clients in addition to providing implementation assistance to clients to comprehend their strategic plans.

Areas of Specialty:

BBC is providing professional assistance to Chinese biomedical firms to introduce their products into global mainstream markets because of our ample experience in R&D of biomedical products, clinical trials and manufacturing quality control as well as comprehensive knowledge in international compliance policies, registration rules, and application regulations of biomedical products. Therefore, we aim to provide flexible and effective modes of collaboration with pharmaceutical companies, research organizations, academic institutions, and government regulatory agencies in China:

  • Routine Consultation
    • If you have any questions or problems when dealing with issues related to FDA regulations, BBC experts or consultants can provide you with much needed assistance and help through our company’s routine consultation services
    • Consulting fee will be charged by the hour (hourly rates)
    • Means of service can be face-to-face discussion, telephone, fax or e-mail communications
  • Retained Consultant
    • If you have any questions or problems when dealing with issues related to FDA regulations, you can retain BBC as your mentor and receive support and help from our experts or consultants
    • Consulting fee will be charged on the basis of a yearly nominal fee
    • Means of service can be face-to-face discussion, telephone, fax or e-mail communications
  • Project-specific Service
    • You may establish a working relationship with us through this service when you are dealing with any issues related to FDA regulations such as wishing to receive support and help from BBC experts or consultants, requiring aid and participation of BBC experts and consultants in your projects, or anything pertaining to contracting particular projects to BBC
    • Consulting fee will be charged based on time spent on different projects
    • BBC's experts or consultants will personally involved in your projects
Managing Director

Managing Director

W. Mel Dong, MBA, PhD, MD

Managing Director, Blue Bell Consulting
Adjunct Professor, Fudan University School of Pharmacy